UK Renal Registry 19th Annual Report: Introduction

Nephron

Volumn 137, Issue 1, 2017, Pages 1-10

  Caskey, Fergus ^a   Steenkamp, Retha ^a   Thomas, Karen ^a  

^a UK RENAL REGISTRY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY FAILURE; CLINICAL ASSESSMENT; CLINICAL AUDIT; CONFIDENTIALITY; DATA BASE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; INCOME; KIDNEY TRANSPLANTATION; MEDICAL RESEARCH; PATIENT CARE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REGISTER; RENAL REGISTRY; REVIEW; SURVIVAL; TOTAL QUALITY MANAGEMENT; UNITED KINGDOM; VASCULAR ACCESS; KIDNEY DISEASE;

HUMANS; KIDNEY DISEASES; REGISTRIES; UNITED KINGDOM;

EID: 85029757119     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000481362     Document Type: Review

References (29)

1. Fotheringham J, Jacques RM, Fogarty D, Tomson CR, El Nahas M, Campbell MJ. Variation in centre-specific survival in patients starting renal replacement therapy in England is explained by enhanced comorbidity information from hospitalization data. Nephrol Dial Transplant 2014; 29(2): 422-30.
2. Health and Social Care Information Centre. Release of health data to the UK Renal Registry (UKRR) Improvements in the analysis of renal care services for patients undergoing renal replacement therapy (RRT). 2014. http://www.hscic.gov.uk/casestudy/renalcareanalysis.
3. Health and Social Care Information Centre. 2014. Original research involving UKRR data 1 The clinical epidemiology of young adults starting renal replacement therapy in the UK: Presentation, management and survival using 15 years of UK Renal Registry data. Hamilton AJ, Casula A, Ben-Shlomo Y, Caskey FJ, Inward CD. Nephrol Dial Transplant. 2017 May 1;32(5):904-905. doi: 10.1093/ndt/gfx046.
4. Lifetime risk of renal replacement therapy in Europe: A population-based study using data from the ERA-EDTA Registry. van den Brand JAJG, Pippias M, Stel VS, Caskey FJ, Collart F, Finne P, Heaf J, Jais JP, Kramar R, Massy ZA, De Meester J, Traynor JP, Reisæter AV, Wetzels JFM, Jager KJ. Nephrol Dial Transplant. 2017 Feb 1;32(2):348-355. doi: 10.1093/ndt/gfw392.
5. Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom. Iwagami M, Tomlinson LA, Mansfield KE, Casula A, Caskey FJ, Aitken G, Fraser SDS, Roderick PJ, Nitsch D. Nephrol Dial Transplant. 2017 Apr 1;32(suppl-2):ii142-ii150. doi: 10.1093/ndt/gfw318.
6. Renal replacement therapy in Europe: A summary of the 2013 ERAEDTA Registry Annual Report with a focus on diabetes mellitus. Kramer A, Pippias M, Stel VS, Bonthuis M, Abad Diez JM, Afentakis N, Alonso de la Torre R, Ambuhl P, Bikbov B, Bouzas Caamanõ E, Bubic I, Buturovic-Ponikvar J, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Comas Farnés J, Garcia Bazaga Mde L, De Meester J, Ferrer Alamar M, Finne P, Garneata L, Golan E, G Heaf J, Hemmelder M, Ioannou K, Kantaria N, Kolesnyk M, Kramar R, Lassalle M, Lezaic V, Lopot F, Macário F, Magaz A, Martn-Escobar E, Metcalfe W, Ots-Rosenberg M, Palsson R, Piñera Celestino C, Resiæ H, Rutkowski B, Santiuste de Pablos C, Spustová V, Stendahl M, Strakosha A, Süleymanlar G, Torres Guinea M, Varberg Reisæter A, Vazelov E, Ziginskiene E, Massy ZA, Wanner C, Jager KJ, Noordzij M. Clin Kidney J. 2016 Jun;9(3):457-69. doi: 10.1093/ckj/sfv151. Epub 2016 Jan 31.
7. Erythropoiesis-stimulating agent dosing, haemoglobin and ferritin levels in UK haemodialysis patients 2005-13. Birnie K, Caskey F, Ben-Shlomo Y, Sterne JA, Gilg J, Nitsch D, Tomson C. Nephrol Dial Transplant. 2017 Apr 1;32(4):692-698. doi: 10.1093/ndt/gfw043.
8. Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry. Pippias M, Stel VS, Aresté-Fosalba N, Couchoud C, Fernandez-Fresnedo G, Finne P, Heaf JG, Hoitsma A, De Meester J, Pálsson R, Ravani P, Segelmark M, Traynor JP, Reisæter AV, Caskey FJ, Jager KJ. Transplantation. 2016 Sep;100(9):1955-62. doi: 10.1097/TP.0000000000000962.
9. The changing trends and outcomes in renal replacement therapy: Data from the ERA-EDTA Registry. Pippias M, Jager KJ, Kramer A, Leivestad T, Sánchez MB, Caskey FJ, Collart F, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hemmelder MH, Kramar R, De Meester J, Noordzij M, Palsson R, Pascual J, Zurriaga O, Wanner C, Stel VS. Nephrol Dial Transplant. 2016 May;31(5):831-41. doi: 10.1093/ndt/gfv327. Epub 2015 Sep 11.
10. Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period van de Luijtgaarden MW, Jager KJ, Segelmark M, Pascual J, Collart F, Hemke AC, Remón C, Metcalfe W, Miguel A, Kramar R, Aasarød K, Abu Hanna A, Krediet RT, Schön S, Ravani P, Caskey FJ, Couchoud C, Palsson R, Wanner C, Finne P, Noordzij M. Nephrol Dial Transplant. 2016 Jan;31(1):120-8. doi: 10.1093/ndt/gfv295. Epub 2015 Aug 26.
11. Kidney Transplantation Significantly Improves Patient and Graft Survival Irrespective of BMI: A Cohort Study. Krishnan N, Higgins R, Short A, Zehnder D, Pitcher D, Hudson A, Raymond NT. Am J Transplant. 2015 Sep;15(9):2378-86. doi: 10.1111/ajt.13363. Epub 2015 Jul 3.
12. Can we routinely measure patient involvement in treatment decisionmaking in chronic kidney care A service evaluation in 27 renal units in the UK. Durand MA, Bekker HL, Casula A, Elias R, Ferraro A, Lloyd A, van der Veer SN, Metcalfe W, Mooney A, Thomson RG, Tomson CR. Clin Kidney J. 2016 Apr;9(2):252-9. doi: 10.1093/ckj/sfw003. Epub 2016 Mar 5.
13. Long-term graft outcomes and patient survival are lower posttransplant in patients with a primary renal diagnosis of glomerulonephritis. Pruthi R, McClure M, Casula A, Roderick PJ, Fogarty D, Harber M, Ravanan R. Kidney Int. 2016 Apr;89(4):918-26. doi: 10.1016/j.kint.2015.11.022. Epub 2016 Jan 21.
14. Predicting 6-month mortality risk of patients commencing dialysis treatment for end-stage kidney disease. Ivory SE, Polkinghorne KR, Khandakar Y, Kasza J, Zoungas S, Steenkamp R, Roderick P, Wolfe R. Nephrol Dial Transplant. 2017 Jan 10. pii: Gfw383. doi: 10.1093/ndt/gfw383. [Epub ahead of print]
15. Measuring senescence rates of patients with end-stage renal disease while accounting for population heterogeneity: An analysis of data from the ERA-EDTA Registry. Koopman JJ, Kramer A, van Heemst D, Åsberg A, Beuscart JB, Buturoviæ-Ponikvar J, Collart F, Couchoud CG, Finne P, Heaf JG, Massy ZA, De Meester JM, Palsson R, Steenkamp R, Traynor JP, Jager KJ, Putter H. Ann Epidemiol. 2016 Nov;26(11):773-779. doi: 10.1016/j.annepidem.2016.08.010. Epub 2016 Aug 31.
16. Early Requirement for RRT in Children at Presentation in the United Kingdom: Association with Transplantation and Survival. Pruthi R, Casula A, Inward C, Roderick P, Sinha MD; British Association for Paediatric Nephrology. Clin J Am Soc Nephrol. 2016 May 6;11(5):795-802. doi: 10.2215/CJN.08190815. Epub 2016 Feb 15.
17. Access to Transplantation and Transplant Outcome Measures (ATTOM): Study protocol of a UK wide, in-depth, prospective cohort analysis. Oniscu GC, Ravanan R, Wu D, Gibbons A, Li B, Tomson C, Forsythe JL, Bradley C, Cairns J, Dudley C, Watson CJ, Bolton EM, Draper H, Robb M, Bradbury L, Pruthi R, Metcalfe W, Fogarty D, Roderick P, Bradley JA; ATTOM Investigators. BMJ Open. 2016 Feb 25;6(2):e010377. doi: 10.1136/bmjopen-2015-010377.
18. Patient attitudes towards kidney transplant listing: Qualitative findings from the ATTOM study. Calestani M, Tonkin-Crine S, Pruthi R, Leydon G, Ravanan R, Bradley JA, Tomson CR, Forsythe JL, Oniscu GC, Bradley C, Cairns J, Dudley C, Watson C, Draper H, Johnson RJ, Metcalfe W, Fogarty DG, Roderick P; ATTOM Investigators. Nephrol Dial Transplant. 2014 Nov;29(11):2144-50. doi: 10.1093/ndt/gfu188. Epub 2014 Jul 4.
19. Routinely measured iohexol glomerular filtration rate versus creatininebased estimated glomerular filtration rate as predictors of mortality in patients with advanced chronic kidney disease: A Swedish Chronic Kidney Disease Registry cohort study. Methven S, Gasparini A, Carrero JJ, Caskey FJ, Evans M. Nephrol Dial Transplant. 2017 Apr 1; 32(suppl-2):ii170-ii179. doi: 10.1093/ndt/gfw457.
20. Quality of Reporting and Study Design of CKD Cohort Studies Assessing Mortality in the Elderly Before and After STROBE: A Systematic Review. Rao A, Brück K, Methven S, Evans R, Stel VS, Jager KJ, Hooft L, Ben-Shlomo Y, Caskey F. PLoS One. 2016 May 11;11(5):e0155078. doi: 10.1371/journal.pone.0155078. eCollection 2016.
21. Patient and disease factors predictive of adverse perioperative outcomes after nephrectomy. Henderson JM, Pitcher D, Steenkamp R, Fowler S, Keeley FX. Ann R Coll Surg Engl. 2016 May;98(5):314-9. doi: 10.1308/rcsann.2016.0126.
22. Early invasive treatment for acute coronary syndrome in patients with chronic kidney disease: Do we know what we're doing Shaw C, Sharpe CC. Future Cardiol. 2015;11(1):5-8. doi: 10.2217/fca.14.71.
23. Strengthening Renal Registries and ESRD Research in Africa. Davids MR, Caskey FJ, Young T, Balbir Singh GK. Semin Nephrol. 2017 May;37(3):211-223. doi: 10.1016/j.semnephrol.2017.02.002.
24. Rationale and design of BISTRO: A randomized controlled trial to determine whether bioimpedance spectroscopy-guided fluid management maintains residual kidney function in incident haemodialysis patients. Davies SJ, Caskey FJ, Coyle D, Lindley E, Macdonald J, Mitra S, Wilkie M, Davenport A, Farrington K, Dasgupta I, Ormandy P, Andronis L, Solis-Trapala I, Sim J. BMC Nephrol. 2017 Apr 26;18(1):138. doi: 10.1186/s12882-017-0554-1.
25. Optimising care for children with kidney disease. Caskey FJ, Morton RL. Lancet. 2017 Mar 20. pii: S0140-6736(17)30267-2. doi: 10.1016/S0140-6736(17)30267-2.
26. Prevalence and incidence of renal disease in disadvantaged communities in Europe. Caskey FJ. Clin Nephrol. 2016 Supplement 1;86 (2016)(13):34-36.
27. A programme to spread eGFR graph surveillance for the early identification, support and treatment of people with progressive chronic kidney disease (ASSIST-CKD): Protocol for the stepped wedge implementation and evaluation of an intervention to reduce late presentation for renal replacement therapy. Gallagher H, Methven S, Casula A, Thomas N, Tomson CR, Caskey FJ, Rose T, Walters SJ, Kennedy D, Dawnay A, Cassidy M, Fluck R, Rayner HC, Nation M. BMC Nephrol. 2017 Apr 11;18(1):131. doi: 10.1186/s12882-017-0522-9.
28. Design and Rationale of 'Tackling Acute Kidney Injury', a Multicentre Quality Improvement Study. Selby NM, Casula A, Lamming L, Mohammed M, Caskey F; Tackling AKI Investigators.Nephron. 2016;134(3):200-204. Epub 2016 Jul 5.
29. How long have I got doctor' The development and validation of a new prognostic model. Steenkamp R, Caskey FJ. Kidney Int. 2015 May;87(5):879-82. doi: 10.1038/ki.2015.36.